A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
· cnbc.com
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
In this article NVO Follow your favorite stocks CREATE FREE ACCOUNT
Michael Siluk | UCG | Universal Images Group | Getty Images
Losing weight with GLP-1 drugs...